Assessing Psychometric Scale Properties of Patient Safety Culture

Jackson, Jeanette; Kline, Theresa

doi:10.1201/9781315599717-10

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to causing grief, these adverse events increase costs in the healthcare system [7]. A conservative assumption from the 2017 Organisation for Economic Co-operation and Development (OECD) report [8], as well as a Canadian study [9], suggests that between 1.3% and 32% of public hospital spending is related to the treatment of adverse events. In the US, adverse events caused excess costs of approximately USD 17.1 billion in 2008, which was 0.72% of the USD 2.39 trillion spent on healthcare during that year [10].…”

Section: Introductionmentioning

confidence: 99%

Assessing the excess costs of the in-hospital adverse events covered by the AHRQ’s Patient Safety Indicators in Switzerland

Giese,

Khanam,

Nghiem

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

There currently exists no comprehensive and up-to date overview on the financial impact of the different adverse events covered by the Patient Safety Indicators (PSIs) from the Agency for Healthcare Research and Quality. We conducted a retrospective case-control study using propensity score matching on a national administrative data set of 1 million inpatients in Switzerland to compare excess costs associated with 16 different adverse events both individually and on a nationally aggregated level. After matching 8,986 cases with adverse events across the investigated PSIs to 26,931 controls, we used regression analyses to determine the excess costs associated with the adverse events and to control for other cost-related influences. The average excess costs associated with the PSI-related adverse events ranged from CHF 1,211 (PSI 18, obstetric trauma with instrument) to CHF 137,967 (PSI 10, postoperative acute kidney injuries) with an average of CHF 27,409 across all PSIs. In addition, adverse events were associated with 7.8-day longer stays, 2.5 times more early readmissions (within 18 days), and 4.1 times higher mortality rates on average. At a national level, the PSIs were associated with CHF 347 million higher inpatient costs in 2019, which corresponds to about 2.2% of the annual inpatient costs in Switzerland. By comparing the excess costs of different PSIs on a nationally aggregated level, we offer a financial perspective on the implications of in-hospital adverse events and provide recommendations for policymakers regarding specific investments in patient safety to reduce costs and suffering.

show abstract

Section: Introductionmentioning

confidence: 99%